In Princeton, New Jersey, on December 10, 2025, CytoSorbents Corporation (NASDAQ: CTSO), known for its expertise in treating critical conditions in the ICU and during cardiac surgery through blood purification, revealed that its CEO, Dr. Phillip Chan, and CFO, Peter J. Mariani,....